AMAG Insider Trading Activity and SEC Form 4 Filings
AMAG insider trading summary
No open-market insider purchases or sales of Amag Pharmaceuticals, Inc. (AMAG) have been reported on SEC Form 4 in the past 12 months.
Latest AMAG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 1, 2020 | Camber Capital Management LP | Insider | Sell | $59.6M (4,390,000 @ $13.57) |
| Mar 16, 2020 | Armistice Capital, LLC | 10% Owner | Buy | $117K (24,000 @ $4.87) |
| Mar 16, 2020 | Steven Boyd | 10% Owner | Buy | $117K (24,000 @ $4.87) |
| Mar 16, 2020 | Armistice Capital Master Fund Ltd. | 10% Owner | Buy | $117K (24,000 @ $4.87) |
| Feb 25, 2020 | Armistice Capital, LLC | 10% Owner | Buy | $99K (12,000 @ $8.29) |
| Feb 25, 2020 | Armistice Capital Master Fund Ltd. | 10% Owner | Buy | $99K (12,000 @ $8.29) |
| Feb 25, 2020 | Steven Boyd | 10% Owner | Buy | $99K (12,000 @ $8.29) |
| Feb 25, 2020 | Armistice Capital Master Fund Ltd. | 10% Owner | Buy | $199K (24,000 @ $8.29) |
| Feb 25, 2020 | Steven Boyd | 10% Owner | Buy | $199K (24,000 @ $8.29) |
| Feb 25, 2020 | Armistice Capital, LLC | 10% Owner | Buy | $199K (24,000 @ $8.29) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.